Business · 07/06/2018Updated: 10/17/2026 · 1 min read
FDA Announces Public Meeting of Pulmonary-Allergy Drugs Advisory Committee
Summary
The FDA is hosting a public meeting of the Pulmonary-Allergy Drugs Advisory Committee to gather input on regulatory issues, and is seeking public comments on the matter, with the meeting to be open to the public.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →